Search

everythinglearnresearchcommunity

for

Search:↓

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Mirtazapine can cause male breast enlargement.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Baricitinib is effective and safe for treating severe alopecia areata.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

Escitalopram might effectively treat delusions of parasitosis and possibly Morgellons disease, with psychological factors being important to consider.

Baricitinib may not always prevent relapse in alopecia areata.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Plica neuropathica can be a sign of schizophrenia and improves with antipsychotic treatment.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.